JC
Juby Chandy
About Juby Chandy
Data last updated:
Juby Chandy is a Whole-Time Director at Glaxosmithkline Pharmaceuticals Limited (since 2022) and Director at Biddle Sawyer Limited (since 2022). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹3,950 Cr; the largest is Glaxosmithkline Pharmaceuticals Limited at ₹3,895 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Glaxosmithkline Pharmaceuticals Limited L24239MH1924PLC001151 | Whole-Time Director | 01 Apr 2022 | 1924 | ₹3,895 Cr (FY 2025) | Active |
 Biddle Sawyer Limited U51900MH1948PLC006218 | Director | 01 Apr 2022 | 1948 | ₹54.40 Cr (FY 2026) | Active |
Board colleagues of Juby Chandy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay Avinash Nadkarni | Glaxosmithkline Pharmaceuticals Limited | Company Secretary | |
| Anup Wadhawan | 03565167 | Glaxosmithkline Pharmaceuticals Limited | Director |
| Bhushan Arun Akshikar | 09112346 | Glaxosmithkline Pharmaceuticals Limited , Biddle Sawyer Limited | Managing Director |
| Manu Anand | 00396716 | Glaxosmithkline Pharmaceuticals Limited | Director |
| Renu Sud Karnad | 00008064 | Glaxosmithkline Pharmaceuticals Limited | Director |
| Ronojit Biswas | 07684843 | Glaxosmithkline Pharmaceuticals Limited | Whole-Time Director |
| Ronojit Biswas | Glaxosmithkline Pharmaceuticals Limited | Cfo | |
| Somasundaram Palamadairamaswamy | 00356363 | Glaxosmithkline Pharmaceuticals Limited | Director |
| Subesh Ronald Williams | 07786724 | Glaxosmithkline Pharmaceuticals Limited | Director |
| Sunita Maheshwari | 01641411 | Glaxosmithkline Pharmaceuticals Limited | Director |
| Ajay Avinash Nadkarni | 03319418 | Biddle Sawyer Limited | Director |
| Rohan Madhukar Mota | Biddle Sawyer Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Juby Chandy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Juby Chandy
Juby Chandy currently holds 2 directorships: Glaxosmithkline Pharmaceuticals Limited (Whole-Time Director, since 01 Apr 2022, revenue ₹3,895 Cr (FY 2025)); Biddle Sawyer Limited (Director, since 01 Apr 2022, revenue ₹54.40 Cr (FY 2026)).
Juby Chandy was first appointed on 01 Apr 2022 as Whole-Time Director at Glaxosmithkline Pharmaceuticals Limited.
The 2 current companies of Juby Chandy that report revenue have a combined latest revenue of ₹3,950 Cr: Glaxosmithkline Pharmaceuticals Limited ₹3,895 Cr (FY 2025); Biddle Sawyer Limited ₹54.40 Cr (FY 2026).
The current boards of Juby Chandy's companies include Ajay Avinash Nadkarni (Glaxosmithkline Pharmaceuticals Limited), Anup Wadhawan (Glaxosmithkline Pharmaceuticals Limited), Bhushan Arun Akshikar (Glaxosmithkline Pharmaceuticals Limited), Manu Anand (Glaxosmithkline Pharmaceuticals Limited), Renu Sud Karnad (Glaxosmithkline Pharmaceuticals Limited), Ronojit Biswas (Glaxosmithkline Pharmaceuticals Limited), among others.